First Time Loading...

Zymeworks Inc
NYSE:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NYSE:ZYME
Watchlist
Price: 8.26 USD 1.85%
Updated: Apr 29, 2024

Zymeworks Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Net Income (Common) Peer Comparison

Comparables:
RPTX
FUSN
AUPH
EDT
SBFM

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NYSE:ZYME
Net Income (Common)
-$118.7m
CAGR 3-Years
13%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Net Income (Common)
-$93.8m
CAGR 3-Years
-21%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Net Income (Common)
-$94.9m
CAGR 3-Years
-6%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Net Income (Common)
-$78m
CAGR 3-Years
9%
CAGR 5-Years
-4%
CAGR 10-Years
-40%
Spectral Medical Inc
TSX:EDT
Net Income (Common)
-CA$15.7m
CAGR 3-Years
-20%
CAGR 5-Years
-44%
CAGR 10-Years
-3%
Sunshine Biopharma Inc
OTC:SBFM
Net Income (Common)
-$4.5m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-6%

See Also

What is Zymeworks Inc's Net Income (Common)?
Net Income (Common)
-118.7m USD

Based on the financial report for Dec 31, 2023, Zymeworks Inc's Net Income (Common) amounts to -118.7m USD.

What is Zymeworks Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-27%

The average annual Net Income (Common) growth rates for Zymeworks Inc have been 13% over the past three years , -27% over the past five years .